Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Janus Electric Secures $2.75M Funding to Advance Zero-Emission Transport Rollout

  • In News
  • March 30, 2026
  • Tim Grey
Janus Electric Secures $2.75M Funding to Advance Zero-Emission Transport Rollout

The transition to zero-emission transport is accelerating as freight and logistics operators seek viable pathways to electrification. With increasing focus on reducing emissions across heavy vehicle fleets, access to capital for technology development and deployment remains a key factor in scaling solutions.

Janus Electric Holdings (ASX:JNS) has secured new funding to support this shift, locking in a $2.75 million R&D finance facility to advance its zero-emission technology roadmap.

The company said the facility supports ongoing development and commercialisation of its battery electric conversion and transport technologies.

Secures Non-Dilutive Funding

The funding has been arranged through a binding R&D finance facility between Janus Energy Pty Ltd, a wholly owned subsidiary, and Rockford RDF Pty Ltd.

The total facility amount is $2.75 million, with funding available for up to 100% of eligible R&D expenditure incurred between July 2025 and February 2026.

Proceeds have already been received and used to repay an existing $1.053 million loan previously provided by Rocking Horse Group.

The structure provides approximately $1.7 million in additional working capital.

Bridges to R&D Tax Incentive

The facility is designed to bridge the company to the receipt of its expected FY25 R&D Tax Incentive refund of $1.41 million from the Australian Taxation Office.

Repayment will be made directly from the FY26 R&D Tax Incentive refund, with the lender nominated to receive the funds.

This approach allows Janus to access capital ahead of the refund while maintaining operational momentum.

Supports Technology Development

The funding is intended to support continued R&D activities tied to Janus’ zero-emission transport platform.

This includes the development and commercialisation of its battery electric conversion technologies for heavy vehicles.

The company is focused on advancing its electrification model for the freight and logistics sector.

Outlines Facility Terms

The facility carries an interest rate of 17% per annum and includes a 1% establishment fee, which has been capitalised.

It has a minimum term of 90 days and a maximum term of 422 days, with repayment due no later than 30 April 2027.

The structure also includes refinancing of the company’s existing FY25 R&D advance facility.

Maintains Liquidity Without Dilution

Janus noted that the facility provides access to non-dilutive capital, helping preserve shareholder value while strengthening near-term liquidity.

This funding approach allows the company to continue progressing its development roadmap without issuing new equity.

As the push toward zero-emission transport gains pace, companies developing electrification technologies are increasingly relying on structured funding solutions to support growth. With this facility in place, Janus is positioned to continue advancing its platform while maintaining financial flexibility.

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  •  
  •  
  •  
  •  
  • ASX:JNS
  • electric utility
  • Janus Electric Holdings
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.